Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lilly and Chugai enter into combinatorial chemistry collaboration

Oct. 29, 1997

Dyax and Tularik establish drug discovery collaboration

Oct. 28, 1997

Structure of NO-producing enzyme solved

Oct. 28, 1997

Sibia's TBA technology licensed to Neurocrine Biosciences

Oct. 28, 1997

Atlantic's 2-5A improves efficacy of antisense compounds

Oct. 24, 1997

CombiChem/Athena initiate CNS drug discovery collaboration

Oct. 21, 1997

Aurora Biosciences licenses fluorescent technology from the University of California

Oct. 21, 1997

PharmaPrint and AHP to collaborate on herbal products

Oct. 20, 1997

Promising preclinical data for Inex's gene delivery system

Oct. 16, 1997

Genetronics evaluates its electroporation therapy in phase II

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...